Loss of Chromosome 18q11.2-q12.1 Is Predictive for Survival in Patients With Metastatic Colorectal Cancer Treated With Bevacizumab

Author(s):
Dijk, E. van; Biesma, H.D.; Cordes, M.; Smeets, D.; Neerincx, M.; ; Eijk, P.P.; Murphy, V.; Barat, A.; Bacon, O.; Prehn, J.H.M.; Betge, J.; Gaiser, T.; Fender, B.; Meijer, G.A.; McNamara, D.A.; Klinger, R.; Koopman, M.; Ebert, M.P.A.; Kay, E.W.; Hennessey, B.T.; Verheul, H.M.W.; Gallagher, W.M.; O'Connor, D.P.; Punt, C.J.A.; Loupakis, F.; Lambrechts, D.; Byrne, A.T.; Grieken, N.C.T. van; Ylstra, B.
Published
2018
Publication type
Article / Letter to editor
Date issued
2018-07-10
Language
English
Is part of
Journal of Clinical Oncology (2018), Vol. 36, no. 20, p. 2052-+
hdl
1887/96466
doi
10.1200/JCO.2017.77.1782